Yahoo
NYSE - Delayed Quote USD

Agilent Technologies, Inc. (A)

150.86 +0.88 (+0.59%)
At close: September 4 at 4:04:11 PM EDT
152.53 +1.67 (+1.11%)
After hours: September 4 at 7:50:03 PM EDT
Trade A on Coinbase
Chart Range Bar
Loading chart for A

What's happening with A?

36m ago
Powered by Yahoo Scout

Agilent reported strong Q3 results with $1.88 billionin revenue and raised full-year guidance. The company launched new products, including the S540MD Slide Scanner Systemand Cary 635 FTIR Spectrometer, enhancing its digital pathology portfolio.

Powered by Yahoo Scout
  • Previous Close 149.98
  • Open 148.97
  • Bid 150.77 x 20000
  • Ask 150.91 x 40000
  • Day's Range 147.78 - 151.59
  • 52 Week Range 108.35 - 163.75
  • Volume 1,808,367
  • Avg. Volume 2,213,320
  • Market Cap (intraday) 42.537B
  • Beta (5Y Monthly) 1.24
  • PE Ratio (TTM) 29.76
  • EPS (TTM) 5.07
  • Earnings Date (est.) Nov 25, 2026
  • Forward Dividend & Yield 1.02 (0.68%)
  • Ex-Dividend Date Jun 30, 2026
  • 1y Target Est 175.45

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

www.agilent.com

18,200

Full Time Employees

October 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

A
11.54%
S&P 500 (^GSPC)
12.75%

1-Year Return

A
18.36%
S&P 500 (^GSPC)
18.71%

3-Year Return

A
26.61%
S&P 500 (^GSPC)
70.93%

5-Year Return

A
12.81%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 1.83B
Earnings 339M
Profit Margin 18.47%

Q4

FY25

Q1

FY26

Q2

FY26

0
500M
1B
2B
18.0%
20.0%
22.0%

Analyst Insights

View More

Analyst Price Targets

155.00
175.45 Average
150.86 Current
190.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/27/2026
Analyst Stifel
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 170 -> 180

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.53%

  • Return on Assets (ttm)

    8.63%

  • Return on Equity (ttm)

    20.97%

  • Revenue (ttm)

    7.37B

  • Net Income Avi to Common (ttm)

    1.44B

  • Diluted EPS (ttm)

    5.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.76B

  • Total Debt/Equity (mrq)

    56.34%

  • Levered Free Cash Flow (ttm)

    1.06B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: